Company Website:
http://lundinlawpc.com
LOS ANGELES -- (Business Wire)
Lundin Law PC (http://lundinlawpc.com/)
announces it is investigating claims against Zosano Pharma Corporation
(“Zosano” or the “Company”) (Nasdaq: ZSAN) concerning possible
violations of federal securities laws.
To get more information about this investigation, please contact Brian
Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at brian@lundinlawpc.com.
No class has been certified in the above action. Until a class is
certified, you are not considered represented by an attorney. You may
also choose to do nothing and be an absent class member.
The investigation concerns whether the Company violated Sections 10(b)
and 20(a) of the Securities Exchange Act of 1934. Specifically, the
investigation will focus on whether the Company's filings with the SEC
concerning its January 2015 Initial Public Offering were misleading. The
Company offered more than 6,500,000 shares of its common stock at $11.00
per share in connection with its IPO.
Lundin Law PC was founded by Brian Lundin, a securities litigator based
in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160826005848/en/
Contacts:
Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile:
888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/
Source: Lundin Law PC
© 2024 Canjex Publishing Ltd. All rights reserved.